Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» sutimlimab
sutimlimab
Sanofi culls early infectious disease, blood disorder asset as it ramps up phase 3 for also-ran COVID vax
Fierce Biotech
Thu, 07/29/21 - 11:09 am
Sanofi
infectious diseases
sutimlimab
Sanofi's treatment for rare anemia hits goal in 2nd phase 3
Fierce Biotech
Fri, 06/11/21 - 10:52 am
Sanofi
clinical trials
sutimlimab
cold agglutinin disease
Sanofi grapples with rejection of potential first-in-class orphan drug, faults third-party manufacturing
Endpoints
Mon, 11/16/20 - 10:25 am
Sanofi
sutimlimab
orphan drugs
FDA
drug manufacturing
Go or no go? Big decisions loom for Bristol and Sanofi
EP Vantage
Fri, 10/30/20 - 10:12 am
FDA
Bristol-Myers Squibb
aducanumab
Sanofi
sutimlimab
Y-mAbs
Danyelza
Sanofi nabs speedy review of sutimlimab, aiming for a November approval
Fierce Biotech
Fri, 05/15/20 - 10:19 am
Sanofi
cold agglutinin disease
sutimlimab
FDA
priority review
ASH: Sanofi eyes FDA filing as orphan blood drug hits late-phase goal
Fierce Biotech
Tue, 12/10/19 - 10:09 am
Sanofi
clinical trials
sutimlimab
ASH2019
cold agglutinin disease